Related Experiment Videos

[Ambulatory myelography using iohexol (Omnipaque): methods and results]

Journal Belge De Radiologie
|June 1, 1989
PubMed

Insights

Outpatient myelography using iohexol is safe and effective, with a low rate of side effects (19%) compared to older agents like metrizamide. This procedure is feasible when iohexol is used and patient surveillance is well-organized.

Area of Science:

  • Radiology
  • Neurology
  • Medical Imaging

Background:

  • Myelography is a diagnostic imaging procedure.
  • Previous studies reported varying side effect profiles with different contrast agents.

Purpose of the Study:

  • To evaluate the safety and feasibility of outpatient myelography using iohexol (Omnipaque).

Main Methods:

  • Outpatient myelography was performed in 150 patients using iohexol.
  • Adverse events were systematically recorded and analyzed.

Main Results:

  • 19% of patients experienced side effects, with only 2% reporting major complaints (headache, seizures).
  • Side effect rates were comparable to hospitalized patients and significantly lower than with metrizamide.
  • Headache was the most common side effect, followed by ischiatiform pain, nausea, and vomiting.

Conclusions:

  • Outpatient myelography with iohexol is a feasible procedure.
  • Careful patient surveillance is crucial for successful outpatient myelography.

Related Concept Videos